12
Participants
Start Date
March 4, 2015
Primary Completion Date
April 24, 2015
Study Completion Date
April 24, 2015
Formulation A
Reference formulation, 10 milligram/milliliter (mg/mL)oral solution without sweetener/flavor.
Formulation B
10 mg/mL oral solution containing 2 mg/mL sucralose, masking flavor and orange flavor.
Formulation C
10 mg/mL oral solution containing 10 mg/mL sucralose.
Formulation D
10 mg/mL oral solution containing 2 mg/mL sucralose and raspberry flavor.
Formulation E
10 mg/mL oral solution containing 2 mg/mL sucralose and strawberry flavor.
Formulation F
10 mg/mL oral solution containing 2 mg/mL sucralose and orange flavor.
Formulation M1
Best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Formulation M2
Best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Formulation M3
Best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Formulation N1
Second best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Formulation N2
Second best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Formulation N3
Second best scoring formulation from Session 1 with a varying concentration of sucralose (maximum 10 mg/mL).
Nottingham
Janssen Sciences Ireland UC
INDUSTRY